elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Epigenome
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Epigenome
RIS
0.001
(Research Intensity Score)
Papers
114
Top papers
Mitochondrial dysfunction in neurodegenerative disorders
2023 · 333 citations
Cadmium Exposure: Mechanisms and Pathways of Toxicity and Implications for Human Health
2024 · 223 citations
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing
2024 · 178 citations
Large-scale manipulation of promoter DNA methylation reveals context-specific transcriptional responses and stability
2022 · 127 citations
Stage-specific H3K9me3 occupancy ensures retrotransposon silencing in human pre-implantation embryos
2022 · 117 citations
Newest papers
Integrated proteomic, transcriptomic, and epigenomic profiling identifies SRA1 as a novel therapeutic target for postpartum depression
2026
Paternal Exposure to Endocrine Disrupting Chemicals and Couples’ Pregnancy Outcomes: A Qualitative Review of the Literature
2026
A Toolbox for Binary and Rheostat-like Modulation of TOX Expression via Genome and Epigenome Editing in Primary Human T cells
2026
Metal carcinogens and cancer: integrating genetic and epigenetic perspectives
2026
Genome-Wide DNA Methylation Profiling Reveals Enrichment of Developmental Vascular and Muscle Programs in Peripheral Artery Disease: A Pilot Epigenome-Wide Association Study
2026
A sample from the 100 top papers behind Epigenome.
Create a free account to browse them all →
Epigenome's history
Research intensity over time
Explore Epigenome's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Epigenome's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link